- Report
- April 2024
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 348 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- January 2023
- 248 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- February 2024
- 265 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- November 2022
- 148 Pages
Global
From €5229EUR$5,500USD£4,393GBP
- Report
- September 2019
- 187 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- May 2023
- 314 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- June 2020
- 145 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- May 2020
- 197 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- October 2023
- 140 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- April 2023
- 85 Pages
Europe
From €3803EUR$4,000USD£3,195GBP
- Report
- February 2024
- 90 Pages
North America
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 117 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2021
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- February 2022
- 120 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP

The Pulmonary Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the lungs. This type of delivery is used to treat a variety of respiratory diseases, such as asthma, COPD, and cystic fibrosis. Pulmonary drug delivery systems are designed to deliver drugs directly to the lungs, allowing for a more targeted and efficient delivery of medication. These systems can be used to deliver both small and large molecules, and can be administered through inhalation, nebulization, or other methods.
The Pulmonary Drug Delivery market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. Show Less Read more